Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas

69Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: This study was designed to investigate EGFR protein expression, EGFR copy number and EGFR mutations in lung adenocarcinomas, to explore the relationship of the three markers.Methods: EGFR status was analyzed in surgically resected lung adenocarcinoma samples from 133 Chinese patients by three methods: protein expression (n = 133) by standardized immunohistochemistry (IHC), gene copy number (n = 133) by fluorescence in situ hybridization (FISH), and mutation analysis using the Scorpion amplification refractory mutation system (ARMS) (n = 133).Results: The results showed that 68.4% of the samples were positive by IHC, 42.1% were positive by FISH, and 63.9% contained activating kinase domain mutations. EGFR mutations were more frequent in non-smoking patients (p = 0.008), and EGFR mutations were associated with EGFR FISH positivity (p < 0.0001). When using 10% positivity and 2+ as cutoffs, EGFR protein expression was significantly correlated with EGFR FISH positivity (p = 0.012) and EGFR mutations (p = 0.008) after Bonferroni correction.Conclusion: EGFR protein expression, EGFR copy number and EGFR mutations were closely related to each other. Standard methods and interpretation criteria need to be established. © 2010 Liang et al; licensee BioMed Central Ltd.

References Powered by Scopus

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib

10558Citations
N/AReaders
Get full text

EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy

8929Citations
N/AReaders
Get full text

Erlotinib in previously treated non-small-cell lung cancer

5255Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

728Citations
N/AReaders
Get full text

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the college of american pathologists, international association for the study of lung cancer, and association for molecular pathology

404Citations
N/AReaders
Get full text

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the study of lung cancer, and Association for Molecular Pathology

391Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liang, Z., Zhang, J., Zeng, X., Gao, J., Wu, S., & Liu, T. (2010). Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas. BMC Cancer, 10. https://doi.org/10.1186/1471-2407-10-376

Readers' Seniority

Tooltip

Researcher 16

57%

PhD / Post grad / Masters / Doc 8

29%

Professor / Associate Prof. 4

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 19

54%

Agricultural and Biological Sciences 9

26%

Biochemistry, Genetics and Molecular Bi... 6

17%

Nursing and Health Professions 1

3%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1980

Save time finding and organizing research with Mendeley

Sign up for free